NovoCure Ltd·4/A

May 17, 4:58 PM ET

Stafford Kristin 4/A

4/A · NovoCure Ltd · Filed May 17, 2023

Insider Transaction Report

Form 4/AAmended
Period: 2023-05-09
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-09+15,87315,873 total
    Exercise: $70.02Exp: 2033-05-08Ordinary Shares (15,873 underlying)
Footnotes (2)
  • [F1]Incorrectly listed in the original filing. This is the correct amount.
  • [F2]These stock options will vest in equal parts on the first, second and third anniversary of the grant date.

Documents

1 file
  • 4
    primarydocument.xml

    PRIMARY DOCUMENT